Equillium (EQ) Change in Receivables (2023 - 2024)
Equillium's (EQ) quarterly Change in Receivables came in at -$5.0 million in Q4 2024, down 14632.35% year-on-year from N/an in Q1 2024, and down 465.99% on a QoQ basis from -$885000.0 in Q3 2024.
Equillium (EQ) Change in Receivables (2023 - 2024) Analysis & Trends
Equillium (EQ) has 2 years of Change in Receivables data on file, last reported at -$5.0 million in Q4 2024.
- On a quarterly basis, Change in Receivables fell 14632.35% year-over-year to -$5.0 million in Q4 2024; TTM through Dec 2024 was -$3.7 million, a 516.39% decrease from a year earlier, with the FY2024 full-year figure at -$3.7 million, down 516.39% from the prior year.
- Change in Receivables for Q4 2024 stood at -$5.0 million, down from -$885000.0 in the prior quarter.
- Over the last five years, Change in Receivables for EQ reached as high as $1.3 million in Q1 2024 and fell as low as -$5.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.01 Mn |
| Dec 31, 2024 | -5.01 Mn |
| Sep 30, 2024 | -885,000.00 |
| Sep 30, 2024 | -885,000.00 |
| Jun 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 846,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | -34,000.00 |
| Dec 31, 2023 | -34,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Mar 31, 2023 | 586,000.00 |
| Mar 31, 2023 | 586,000.00 |